Mutations in the kinase domain of BRAF, specifically found at the V600 site, are frequently found to be drivers of cancer, including a prevalence of mutations noted in, but not exclusive to, melanoma, colorectal cancer, non‐small cell lung cancer and differentiated thyroid cancer.1, 2, 3, 4, 5. Here, BRAF is linked to colorectal cancer.